I cringed when I heard him say that. I certainly hope everyone hear checks and verifies every link I have posted for themselves. I’m definitely not an expert by any stretch of the imagination. I’m trying to get answers just like everyone here. I share what I find, that’s all. I could be misinterpreting the meaning of those graphs. Decide for yourselves, that’s why I try to always add links. I’m just some dude posting on a message board with no professional qualifications outside of what Google tells me.
I actually decided earlier today that I would try and write Dr.Perry myself to provide him with my DD that I posted here. I would love to know what he thinks about it’s validity. If he replies I’ll definitely share it if he ok’s it.
I can only comment that I believe I have shown another instance where a PHD who writes for (Alzheimer’s news today) seems to have been befuddled by Anavex’s graphical data as well.
Likely Dr George Perry will be the principle investigator of The USA arm of the upcoming A2-73 Alzheimer's Trial. That is the most likely reason. There will likely be big surprises for this trial. Once the trial details are released on November 4th all will be clear and will seem that it should have been obvious to many. It is obvious to me already. Dr. Perry is on board as the independent investigator in the USA. Likely the CRO is in place as well as the IND already approved by the FDA. Further there is a substantial likelihood that the USA CRO will have direct funding from a US Govt. Program. Shocking as this maybe to the naysayers, Anavex has been very busy behind the scenes and there has been a lot of progress that will be evident soon. Get it? Got it? Good! HaHa Go AVXL!